Breaking News

Vetter to Invest €300M in Additional Manufacturing Capacity

Will more than double current capacity at three German sites

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Vetter is investing approximately €300 million to expand and upgrade its manufacturing facilities during the next five years. The company is preparing for future needs and requirements driven by a changing healthcare market that is affected by issues such as more complex molecules, smaller batch sizes, and increasing regulatory requirements.   The first of the facility expansions are underway at several German locations including its ‘Ravensburg Vetter West’ center for visual inspection and lo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters